1 insider has bought $589k of Oncology Institute, Inc. shares across 6 disclosed dealings since May 2026. 4 of those have been scored against our six-point signal check.
| Jul 21, 2026 | Chernett Jorey — 10% owner | $94,860 |
| Jul 10, 2026 | Chernett Jorey — 10% owner | $87,750 |
| Jun 23, 2026 | Chernett Jorey — 10% owner | $90,360 |
| Jun 4, 2026 | Chernett Jorey — 10% owner | $57,000 |
| May 20, 2026 | Chernett Jorey — 10% owner | $136,345 |
| May 19, 2026 | Chernett Jorey — 10% owner | $122,700 |
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.